Published in Cell Adh Migr on January 01, 2015
Tenascin-C drives persistence of organ fibrosis. Nat Commun (2016) 1.41
Inflammation as a Keystone of Bone Marrow Stroma Alterations in Primary Myelofibrosis. Mediators Inflamm (2015) 0.90
Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization. Adv Drug Deliv Rev (2016) 0.79
Evidence of Active Pro-Fibrotic Response in Blood of Patients with Cirrhosis. PLoS One (2015) 0.75
Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature (2003) 20.48
Cellular and molecular mechanisms of fibrosis. J Pathol (2008) 14.01
The extracellular matrix: not just pretty fibrils. Science (2009) 8.52
Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med (2012) 6.15
Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med (2009) 3.87
Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat Genet (1997) 2.56
The myofibroblast: paradigm for a mechanically active cell. J Biomech (2009) 2.53
Induction of tenascin in healing wounds. J Cell Biol (1988) 2.45
Tenascins: regulation and putative functions during pathological stress. J Pathol (2003) 2.44
Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition. Nat Genet (2002) 1.60
Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury. Am J Pathol (2005) 1.46
Tenascin and fibronectin expression in healing human myocardial scars. J Pathol (1996) 1.40
Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis. Am J Pathol (2001) 1.33
Tenascins and the importance of adhesion modulation. Cold Spring Harb Perspect Biol (2011) 1.29
Extracellular matrix-derived products modulate endothelial and progenitor cell migration and proliferation in vitro and stimulate regenerative healing in vivo. Matrix Biol (2010) 1.27
Transcriptional regulation of the endogenous danger signal tenascin-C: a novel autocrine loop in inflammation. J Immunol (2010) 1.25
Tenascin-C modulates adhesion of cardiomyocytes to extracellular matrix during tissue remodeling after myocardial infarction. Lab Invest (2001) 1.22
Treatment targets in renal fibrosis. Nephrol Dial Transplant (2007) 1.19
How does TGF-β mediate tubulointerstitial fibrosis? Semin Nephrol (2012) 1.14
Tenascin-C is induced by mutated BMP type II receptors in familial forms of pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol (2006) 1.13
Deficiency of tenascin-C attenuates liver fibrosis in immune-mediated chronic hepatitis in mice. J Pathol (2007) 1.11
Ongoing angiogenesis in blood vessels of the abdominal aortic aneurysm. Exp Mol Med (2004) 1.09
Tenascin-C may aggravate left ventricular remodeling and function after myocardial infarction in mice. Am J Physiol Heart Circ Physiol (2010) 1.08
Regulation of fibroblast migration by tenascin-C. Biochem Soc Trans (2007) 1.08
Eplerenone attenuates myocardial fibrosis in the angiotensin II-induced hypertensive mouse: involvement of tenascin-C induced by aldosterone-mediated inflammation. J Cardiovasc Pharmacol (2007) 1.05
Alpha9 integrin and its ligands constitute critical joint microenvironments for development of autoimmune arthritis. J Immunol (2009) 1.04
Tenascin-C deficiency attenuates TGF-ß-mediated fibrosis following murine lung injury. Am J Physiol Lung Cell Mol Physiol (2010) 1.03
Localized expression of tenascin in systemic sclerosis-associated pulmonary fibrosis and its regulation by insulin-like growth factor binding protein 3. Arthritis Rheum (2012) 0.96
Extracellular matrix proteins: a positive feedback loop in lung fibrosis? Matrix Biol (2013) 0.96
Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease. Alcohol Clin Exp Res (2008) 0.96
Novel combination of collagen dynamics analysis and transcriptional profiling reveals fibrosis-relevant genes and pathways. Matrix Biol (2013) 0.94
Oxidative damage and TGF-β differentially induce lung epithelial cell sonic hedgehog and tenascin-C expression: implications for the regulation of lung remodelling in idiopathic interstitial lung disease. Int J Exp Pathol (2010) 0.94
Elevation of serum and urine levels of TIMP-1 and tenascin in patients with renal disease. Nephrol Dial Transplant (2002) 0.94
The role of tenascin C in cardiovascular disease. Cardiovasc Res (2011) 0.94
Cardiomyopathy is associated with structural remodelling of heart valve extracellular matrix. Eur Heart J (2009) 0.92
Deficiency of tenascin C attenuates allergen-induced bronchial asthma in the mouse. Eur J Immunol (2006) 0.92
Tenascin supports lymphocyte rolling. J Cell Biol (1997) 0.92
Tenascin immunoreactivity as a prognostic marker in usual interstitial pneumonia. Am J Respir Crit Care Med (1996) 0.92
Comparative immunohistochemical staining of atherosclerotic plaques using F16, F8 and L19: Three clinical-grade fully human antibodies. Atherosclerosis (2009) 0.92
Inhibition of T cell activation by the extracellular matrix protein tenascin. J Immunol (1994) 0.91
Localization of tenascin in human skin wounds--an immunohistochemical study. Int J Legal Med (1993) 0.91
Tenascin expression during wound healing in human skin. J Pathol (1996) 0.90
A model of tenascin-X integration within the collagenous network. FEBS Lett (2006) 0.90
Tenascins in stem cell niches. Matrix Biol (2014) 0.89
Tenascin expression and distribution in pleural inflammatory and fibrotic diseases. J Histochem Cytochem (2000) 0.89
Tenascin-X increases the stiffness of collagen gels without affecting fibrillogenesis. Biophys Chem (2010) 0.89
Arterialization of human vein grafts is associated with tenascin-C expression. J Am Coll Cardiol (1999) 0.87
Effect of tenascin-C deficiency on chemically induced dermatitis in the mouse. J Invest Dermatol (1998) 0.87
Tenascin-X promotes epithelial-to-mesenchymal transition by activating latent TGF-β. J Cell Biol (2014) 0.86
Tenascin immunoreactivity in cryptogenic fibrosing alveolitis. J Pathol (1995) 0.86
Induction of tenascin in rat lungs undergoing bleomycin-induced pulmonary fibrosis. Am J Physiol (1998) 0.86
Tenascin-C and mechanotransduction in the development and diseases of cardiovascular system. Front Physiol (2014) 0.86
Distinct tissue distribution in pigs of tenascin-X and tenascin-C transcripts. Eur J Biochem (1995) 0.86
Ultrastructural features of lung fibroblast differentiation into myofibroblasts. Ultrastruct Pathol (2009) 0.86
Propranolol impairs the closure of pressure ulcers in mice. Life Sci (2014) 0.84
Expression of tenascin-C splice variants in normal and bullous keratopathy human corneas. Invest Ophthalmol Vis Sci (1998) 0.84
Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha. World J Gastroenterol (2006) 0.84
Increased expression of tenascin C by keloids in vivo and in vitro. Br J Dermatol (1999) 0.83
Impaired cornea wound healing in a tenascin C-deficient mouse model. Lab Invest (2012) 0.83
Suppression of injury-induced epithelial-mesenchymal transition in a mouse lens epithelium lacking tenascin-C. Mol Vis (2010) 0.83
Tenascin is increased in epithelial lining fluid in fibrotic lung disorders. Lung (1998) 0.83
Expression of tenascin, fibronectin, and laminin in rat liver fibrogenesis--a comparative immunohistochemical study with two models of liver injury. Exp Toxicol Pathol (1998) 0.82
Tenascin: a sensitive and specific diagnostic marker of minimal collagenous colitis. Virchows Arch (2001) 0.82
Tenascin expression is associated with a chronic inflammatory process in abdominal aortic aneurysms. J Vasc Surg (1997) 0.82
Tenascin-C is associated with coronary plaque instability in patients with acute coronary syndromes. Circ J (2004) 0.82
Mild muscular features in tenascin-X knockout mice, a model of Ehlers-danlos syndrome. Connect Tissue Res (2011) 0.82
Tenascin-C expression in normal, inflamed, and scarred human corneas. Br J Ophthalmol (1997) 0.81
Elevated levels of tenascin-C in patients with cryptogenic organizing pneumonia. Intern Med (2009) 0.80
Tenascin suppresses CD3-mediated T cell activation. Biochem Biophys Res Commun (1998) 0.80
Quantitative analysis of tenascin in chordae tendineae of human left ventricular papillary muscle with aging. Ann Anat (2001) 0.80
Characterization of fibrosis-promoting factors and siRNA-mediated therapies in C-protein-induced experimental autoimmune myocarditis. Cell Immunol (2012) 0.79
Unlike tenascin-X, tenascin-C is highly up-regulated in pig cutaneous and underlying muscle tissue developing fibrosis after necrosis induced by very high-dose gamma radiation. Radiat Res (1998) 0.79
Elevated tenascin-C levels in bronchoalveolar lavage fluid of patients with sarcoidosis. Lung (2012) 0.78
Serum levels of tenascin-C in collagen diseases. J Dermatol (2013) 0.78
Iron chelator alleviates tubulointerstitial fibrosis in diabetic nephropathy rats by inhibiting the expression of tenascinC and other correlation factors. Endocrine (2013) 0.78
Can serum tenascin-C be used as a marker of inflammation in patients with dilated cardiomyopathy? Int J Pediatr (2013) 0.76
The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature (1999) 4.55
The CCR7 ligand elc (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment. J Exp Med (2001) 2.19
Regional specialization in the mucosal immune system: primed cells do not always home along the same track. Immunol Today (1999) 1.56
Rapid secretion of prestored interleukin 8 from Weibel-Palade bodies of microvascular endothelial cells. J Exp Med (1998) 1.55
B cell attracting chemokine 1 (CXCL13) and its receptor CXCR5 are expressed in normal and aberrant gut associated lymphoid tissue. Gut (2002) 1.14
Expression of functional VCAM-1 by cultured nasal polyp-derived microvascular endothelium. Am J Pathol (1997) 1.12
Respiratory burst of intestinal macrophages in inflammatory bowel disease is mainly caused by CD14+L1+ monocyte derived cells. Gut (1995) 1.11
Cytokine profiles of cultured microvascular endothelial cells from the human intestine. Gut (1998) 1.08
Immunopathology of human inflammatory bowel disease. Springer Semin Immunopathol (1997) 1.07
Eosinophil infiltration is related to increased expression of vascular cell adhesion molecule-1 in nasal polyps. Am J Respir Cell Mol Biol (1995) 1.05
Heterogeneity of endothelial cells: the specialized phenotype of human high endothelial venules characterized by suppression subtractive hybridization. Am J Pathol (1999) 1.04
Culture characterization of differentiated high endothelial venule cells from human tonsils. Lab Invest (1999) 0.91
Mechanism for enhanced external transfer of dimeric IgA over pentameric IgM: studies of diffusion, binding to the human polymeric Ig receptor, and epithelial transcytosis. J Immunol (1997) 0.85
Mucosal immunology of the upper airways: an overview. Ann N Y Acad Sci (1997) 0.84
Cellular and molecular mechanisms for induction of mucosal immunity. Dev Biol Stand (1998) 0.83
Immunofluorescent evidence for presence of interleukin-1 in normal and diseased human skeletal muscle. Muscle Nerve (1988) 0.81
Human serum-induced expression of E-selectin on porcine aortic endothelial cells in vitro is totally complement mediated. Transplantation (2001) 0.79
Human intestinal endothelium shows high susceptibility to cytomegalovirus and altered expression of adhesion molecules after infection. Scand J Immunol (2000) 0.79
Mucosal immunity--a major adaptive defence mechanism. Behring Inst Mitt (1997) 0.79
Differential interference contrast microscopy combined with immunofluorescence: a new method to phenotype eosinophils in situ. J Immunol Methods (1994) 0.78
Genome-wide transcription profile of endothelial cells after cardiac transplantation in the rat. Am J Transplant (2010) 0.75
C1-inhibitor attenuates human serum induced E-selectin expression of pig aortic endothelial cells. Transplant Proc (2001) 0.75
Expression of the T cell-specific adapter protein in human tissues. Scand J Immunol (2014) 0.75